Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8104848 | 0.93 | ALDH1A1 (0.50) | ALDH1A1RNPEPNPC1MAPTSMN1; SMN2 | |
| SCHEMBL7793662 | 0.81 | DGKA (0.52) | ALDH1A1MAPTTSHRLMNA | |
| Iodide SCHEMBL6069090 | 0.80 | DGKA (0.50) | ALDH1A1NAAAMAPTTSHRLMNA | |
| SCHEMBL21518705 | 0.79 | ALDH1A1 (0.67) | ALDH1A1NAAAMAPTSMN1; SMN2TSHR | |
| SCHEMBL10428923 | 0.77 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL1448036 | 0.76 | — | — | |
| SCHEMBL9276 | 0.76 | — | — | |
| SCHEMBL857398 | 0.75 | — | — | |
| SCHEMBL18126413 | 0.74 | ALDH1A1 (0.60) | ALDH1A1NAAAMAPTTSHRLMNA | |
| SCHEMBL8164255 | 0.74 | ALDH1A1 (0.88) | ALDH1A1NAAATSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6117902-A | 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors | GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) | 2000-09-12 | — | — | US | disclosed |